JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB145871

Pyridoxal isonicotinoyl hydrazone (PIH), hydrazone iron chelator

Be the first to review this product! Submit a review

|

(3 Publications)

MW 286.29 Da, Purity >99%. Cell-permeable non-toxic hydrazone iron chelator. Prevents iron-mediated oxyradical formation and minimizes tissue damage. Anticancer and apoptotic agent. Active in vitro.

See similar compounds.
1 Images
Chemical Structure - Pyridoxal isonicotinoyl hydrazone (PIH), hydrazone iron chelator (AB145871)
  • Chemical Structure

Lab

Chemical Structure - Pyridoxal isonicotinoyl hydrazone (PIH), hydrazone iron chelator (AB145871)

2D chemical structure image of ab145871, Pyridoxal isonicotinoyl hydrazone (PIH), hydrazone iron chelator

Key facts

CAS number

737-86-0

Purity

>99%

Form

Solid

form

Molecular weight

286.29 Da

Molecular formula

C<sub>1</sub><sub>4</sub>H<sub>1</sub><sub>4</sub>N<sub>4</sub>O<sub>3</sub>

PubChem

135409539

Nature

Synthetic

Solubility

Soluble in DMSO to 100 mM

Biochemical name

Pyridoxal isonicotinoyl hydrazone

Biological description

Cell-permeable non-toxic hydrazone iron chelator. Prevents iron-mediated oxyradical formation and minimizes tissue damage. Anticancer and apoptotic agent. Active in vitro.

See similar compounds

Canonical smiles

CC1=NC=C(C(=C1O)C=NNC(=O)C2=CC=NC=C2)CO

Isomeric smiles

CC1=NC=C(C(=C1O)/C=N/NC(=O)C2=CC=NC=C2)CO

InChi

InChI=1S/C14H14N4O3/c1-9-13(20)12(11(8-19)6-16-9)7-17-18-14(21)10-2-4-15-5-3-10/h2-7,19-20H,8H2,1H3,(H,18,21)/b17-7+

InChiKey

BQYIXOPJPLGCRZ-REZTVBANSA-N

IUPAC Name

N-[(E)-[3-hydroxy-5-(hydroxymethyl)-2-methylpyridin-4-yl]methylideneamino]pyridine-4-carboxamide

Properties and storage information

Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C
Storage information
It is important to note that this product is reported to be light sensitive|Store in the dark|Store under desiccating conditions

Product protocols

Publications (3)

Recent publications for all applications. Explore the full list and refine your search

PLoS pathogens 21:e1012857 PubMed39899594

2025

Iron-mediated post-transcriptional regulation in Toxoplasma gondii.

Applications

Unspecified application

Species

Unspecified reactive species

Megan A Sloan,Adam Scott,Dana Aghabi,Lucia Mrvova,Clare R Harding

eLife 10: PubMed33526170

2021

Iron derived from autophagy-mediated ferritin degradation induces cardiomyocyte death and heart failure in mice.

Applications

Unspecified application

Species

Unspecified reactive species

Jumpei Ito,Shigemiki Omiya,Mara-Camelia Rusu,Hiromichi Ueda,Tomokazu Murakawa,Yohei Tanada,Hajime Abe,Kazuki Nakahara,Michio Asahi,Manabu Taneike,Kazuhiko Nishida,Ajay M Shah,Kinya Otsu

Cell reports 30:3250-3260.e7 PubMed32160534

2020

Lipid Oxidation Induced by RF Waves and Mediated by Ferritin Iron Causes Activation of Ferritin-Tagged Ion Channels.

Applications

Unspecified application

Species

Unspecified reactive species

Miriam Hernández-Morales,Trisha Shang,Jingjia Chen,Victor Han,Chunlei Liu
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com